What's Happening?
A recent study published in the journal Nature Metabolism has found that glucosamine, a common supplement used for joint pain, may accelerate memory loss in individuals with Alzheimer's disease. The research, conducted by a team at the University of Florida,
analyzed anonymized medical records of 24,000 patients with dementia and 41,000 with mild cognitive impairment. The study revealed that Alzheimer's patients taking glucosamine were 25% more likely to die within five years compared to those who did not take the supplement. Additionally, individuals with mild cognitive impairment taking glucosamine were 25% more likely to progress to full Alzheimer's. Experiments on mice with Alzheimer's-like symptoms showed that blocking the enzyme responsible for producing sugars like glucosamine improved dementia symptoms, whereas feeding glucosamine worsened memory loss.
Why It's Important?
The findings of this study are significant as they challenge the perceived safety of glucosamine, a widely used supplement by over 40 million Americans annually. While glucosamine is classified as a dietary supplement by the FDA and available over the counter, its potential adverse effects on cognitive health in Alzheimer's patients raise concerns. This research suggests that while glucosamine may be safe for healthy individuals, it could be harmful to those already experiencing cognitive decline. The study highlights the need for further investigation into the effects of glucosamine and similar supplements on brain health, particularly in vulnerable populations.
What's Next?
Future research is needed to determine whether glucosamine directly causes cognitive decline in Alzheimer's patients. A potential clinical trial could involve monitoring patients who discontinue glucosamine to assess changes in cognitive decline. Additionally, the research team plans to explore other compounds that block sugar buildup on brain cells, which may help slow or reverse Alzheimer's disease. Further studies are also needed to understand the impact of glucosamine dosage, brand, and duration of use on cognitive health.
